The defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesterase

Clin Exp Immunol. 1992 Jul;89(1):89-93. doi: 10.1111/j.1365-2249.1992.tb06883.x.

Abstract

Lymphocytes infected in vivo with HIV or lymphoblastoid cells exposed in vitro to either HIV or its envelope glycoprotein (gp120) show a defect in inositol polyphosphate-mediated signal transduction together with an associated abnormality in intracellular calcium regulation. The defect in patients reverses after treatment with the anti-retroviral agent zidovudine (AZT). We present evidence that the defect is at the level of the Ins (1,3,4,5)P4 5-phosphomonoesterase (PME) in these cells and that, though elevation of the intracellular ATP level partially down-regulates the activity of this enzyme, such changes alone are unable to account for the complete inhibition seen in HIV-infected cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Calcium / pharmacology
  • Chromatography, High Pressure Liquid
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • HIV / metabolism*
  • HIV Envelope Protein gp120 / immunology
  • Humans
  • Hydrolysis
  • Inositol Polyphosphate 5-Phosphatases
  • Lymphocytes / metabolism*
  • Phosphatidylinositols / metabolism*
  • Phosphoric Monoester Hydrolases / physiology*
  • Signal Transduction
  • Zidovudine / pharmacology

Substances

  • HIV Envelope Protein gp120
  • Phosphatidylinositols
  • Zidovudine
  • Adenosine Triphosphate
  • Phosphoric Monoester Hydrolases
  • Inositol Polyphosphate 5-Phosphatases
  • Calcium